Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

NCT05726084 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

16304

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19
Coronavirus Infections
Respiratory Tract Infections
COVID-19 Respiratory Infection

Interventions

BIOLOGICAL: Subunit recombinant vaccine for the prevention of coronavirus infection
BIOLOGICAL: Placebo

Sponsor

St. Petersburg Research Institute of Vaccines and Sera